Yahoo Finance The Zacks Analyst Blog Highlights Johnson & Johnson, Disney, Uber, Goldman Sachs and Elevance Health
For Immediate Release
Chicago, IL – February 12, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson JNJ, The Walt Disney Co. DIS, Uber Technologies, Inc. UBER, The Goldman Sachs Group, Inc. GS and Elevance Health, Inc. ELV.
Here are highlights from Friday’s Analyst Blog:
Top Research Reports for J&J, Walt Disney and Uber
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, The Walt Disney Co. and Uber Technologies, Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of Johnson & Johnson have underperformed the Zacks Large Cap Pharmaceuticals industry over the past six months (-7.8% vs. +12.2%). The company is witnessing headwinds like generic competition and pricing pressure. J&J faces the upcoming patent expiration of Stelara. Though it has taken meaningful steps to resolve its talc and opioid litigation, uncertainty regarding the talc litigations persists.
Nevertheless, Johnson & Johnson’s innovative Medicine unit is performing at above-market levels. Growth is being driven by existing products like Darzalex, Stelara, Tremfya and Erleada, and also continued uptake of new launches, including Spravato, Carvykti and Tecvayli.
The MedTech unit is showing improving trends, driven by a recovery in surgical procedures and contribution from new products. J&J is making rapid progress with its pipeline and line extensions.
(You can read the full research report on Johnson & Johnson here >>>)
Walt Disney’s shares have outperformed the Zacks Media Conglomerates industry over the past six months (+20.9% vs. +14.4%). The company’s results reflect a solid revival in international theme park and resort businesses. Recent attractions like the Frozen theme land at Hong Kong Disneyland and Walt Disney Park in Paris, as well as the Zootopia theme land at Shanghai Disney, are expected to boost the prospects of the theme park business.
Disney’s declining ad revenues due to fewer impressions has been a headwind for some time now. Disney+’s profitability is expected to be negatively impacted by higher investments in content, which will increase programming and production costs at Media and Entertainment Distribution.
However, its leveraged balance sheet remains a concern. Disney+ is facing tough competition in the streaming market from the likes of Netflix and Amazon Prime Video.
(You can read the full research report on Walt Disney here >>>)
Shares of Uber Technologies have outperformed the Zacks Internet - Services industry over the past six months (+60.6% vs. +14.9%). The company’s delivery business benefits from rising online order volumes. The company’s efforts to expand its delivery operations through successive acquisitions are encouraging. Continued recovery in Mobility operations is aiding the company.
For first-quarter 2024, Uber expects gross bookings of $37 billion-$38.5 billion. With focus on financial discipline, recovery in Mobility operations and the strong performance of the Delivery unit, betterment in Uber’s Adjusted EBITDA is encouraging. For first-quarter 2024, adjusted EBITDA is estimated between $1.26 billion and $1.34 billion.
On the flip side, Uber contines to witness high costs and expenses owing to rise in sales and marketing expenses and cost of revenues. Increased spending on driver incentives is also pushing up costs. High debt continues to act as another major concern.
(You can read the full research report on Uber here >>>)
Other noteworthy reports we are featuring today include The Goldman Sachs Group, Inc. and Elevance Health, Inc.
Why Haven’t You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Goldman Sachs Group, Inc. (GS) : Free Stock Analysis Report
Johnson & Johnson (JNJ) : Free Stock Analysis Report
The Walt Disney Company (DIS) : Free Stock Analysis Report
Uber Technologies, Inc. (UBER) : Free Stock Analysis Report
Elevance Health, Inc. (ELV) : Free Stock Analysis Report
